Peptides and hormonal signalling
Two mechanisms, two very different positions in the regulatory landscape. One compound here has been through an approval process; another is structurally related to a compound regulators have warned about. Those distinctions are the substance of this page.
Upstream signals, downstream receptors
The first mechanism is central rather than peripheral. Melanocortin receptors in the brain are involved in a range of signalling, and one compound studied here acts on that system. It is structurally related to a pigmentation compound that European regulators have issued notices about, which is a relationship worth understanding before you read either literature.
The second sits further upstream. Kisspeptin acts on the axis that governs reproductive hormone release, which makes it a research target for questions about how that system is regulated rather than about any downstream outcome.
One of the compounds on this page holds an approval for a specific indication in some jurisdictions. That does not make the research material we supply the same product, and the compound page is explicit about where that line runs.
What is being investigated- Melanocortin receptor signalling in the central nervous system
- The reproductive hormone axis and upstream regulation
- Structural relationships between related compounds
- Which compounds hold approvals, and where
Where this sits legally
PT-141 is approved under the name bremelanotide in some jurisdictions for a specific indication. Same molecule name, entirely different product, different obligations attached.
Compounds studied here
Two items, one acting centrally and one acting upstream of the hormone axis.
What this page leaves out
No outcome claims of any kind, which in this area matters more than most. One compound here is structurally related to something regulators have published notices about, and another holds an approval elsewhere that does not transfer to research material. We keep those two facts visible rather than letting them blur.
Read before you order
Four pages, including the regulatory notices on the structurally related compound.
PT-141
Also catalogued as bremelanotide, and how it relates structurally to melanotan 2.
Read CompoundKisspeptin
A peptide upstream of the reproductive hormone axis, and why that position makes it interesting.
Read CompoundMelanotan 2
The structurally related compound, including the regulatory notices published about it.
Read FrameworkResearch use only
The legal category this material sits in, and what that permits.
ReadQuestions about this area
Almost always about the line between an approved medicine and research material.
How is PT-141 related to melanotan 2?
Does an approval elsewhere make this a medicine?
Why is Kisspeptin in this area?
Why is one product a combination?
Are these compounds on the WADA list?
Two mechanisms, two legal positions
The distinction between an approved medicine and research material is the whole point of this page. We supply the second, and we do not blur the difference.
For laboratory and research use only. Not for human or animal consumption. Not a medicine and not a food supplement. Sold to persons aged 18 and over. Compounds named on this page may appear on the WADA prohibited list.

